Revocation of New York Ruling Letter N233631; classification of Linzess® (Linaclotide) (CAS-851199-59-2); Guanylate Cyclase-C Agonist

Reasoning

Revocation of New York Ruling Letter N233631; classification of Linzess® (Linaclotide) (CAS-851199-59-2); Guanylate Cyclase-C Agonist

Cite this ruling

CBP Ruling H250309 (30029050): Revocation of New York Ruling Letter N233631; classification of Linzess® (Linaclotide) (CAS-851199-59-2); Guanylate Cyclase-C Agonist

Paste this into a product's override reason when citing this ruling as justification for a classification.

Other rulings for HS6 300290